Escitalopram Oxalate Solution
Product Images NDC 65862-248

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Escitalopram Oxalate (NDC 65862-248). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (5 mg/5 mL (240 mL Bottle))

Label for Escitalopram Oral Solution USP, 5 mg/5 mL strength, in a 240 mL bottle. Distributed by Aurobindo Pharma USA, Inc. The label includes storage instructions, dosage information to see package insert, and warnings to keep out of reach of children. Made in India with NDC 65862-248-24 indicated.*

FDA Label Image

Escitalopram Fig2

Packaging label for Escitalopram Oral Solution USP 5 mg/5 mL by Aurobindo Pharma Limited. The label indicates a 240 mL oral solution with directions for pharmacists to dispense with a medication guide. Storage instructions and distributor details (Aurobindo Pharma USA, Inc.) are visible, along with regulatory and barcode information.*

FDA Label Image

Chemical Structure (Escitalopram Str)

Chemical structure of Escitalopram Oxalate shown with its molecular components and the oxalate salt indicated by the formula C2H2O4.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.